Immune reconstitution following allogeneic peripheral blood stem cell transplants

Bone Marrow Transplantation

Volumn 23, Issue 4, 1999, Pages 335-346

  Shenoy, S ^a   Mohanakumar, T ^a   Todd, G ^a   Westhoff, W ^a   Dunnigan, K ^a   Adkins, D R ^a   Brown, R A ^a   Dipersio, J F ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Cytokines; GVHD; Immune reconstitution; Lymphocyte function; PBSCT

Indexed keywords

BUSULFAN; CALCIUM ION; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; ETOPOSIDE; GAMMA INTERFERON; HLA ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 10; MESSENGER RNA; MITOGENIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; LEUKEMIA; LYMPHOCYTE FUNCTION; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIREMIA;

EID: 0033041419     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701581     Document Type: Article

References (72)

1. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843.
2. Storb R, Thomas ED, Weiden PL et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood 1976; 48: 817-841.
3. Thomas ED, Buckner CD, Banaji M et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977; 49: 511-533.
4. Henon PR, Liang H, Beck-Wirth G et al. Comparison of haemopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1997; 9: 285-291.
5. Kiesel S, Pezzutto A, Korbling M et al. Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery. Transpl Proc 1989; 21: 3084-3088.
6. Appelbaum FR. Hemopoietic reconstitution following autologous bone marrow and peripheral blood mononuclear cell infusion. Exp Hematol 1979; 7: 7-11.
7. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1655-1658.
8. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow graft. Blood 1995; 85: 1659-1665.
9. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood stem cells mobilized by filgrastim (granulocyte colony stimulating factor). Blood 1995; 85: 1666-1672.
10. Russel N, Gratwohl A, Schmitz N. The place of blood stem cells in allogeneic transplantation. Br J Haematol 1996; 93: 747-753.
11. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1415.
12. Kessinger A, Armitage J, Bierman P et al. Clinical outcome of peripheral blood stem cell support. Med Oncol 1994; 11: 43-46.
13. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994; 84: 2795-2801.
14. Weaver CH, Longin K. Buckner CD, Bensinger W. Lymphocyte content in peripheral blood mononuclear cells collected after administration of recombinant granulocyte colony stimulating factor. Bone Marrow Transplant 1994; 13: 411.
15. Talmadge JE, Reed EC, Kessinger A et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
16. Mills KC, Gross TG, Varney ML et al. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Bone Marrow Transplant 1996; 18: 53-61.
17. - progenitors in normal allogeneic PBSC donors. Blood 1996; 88: 679a.
18. Hassan HT, Stockschlader M, Schleimer B et al. Comparison of the content and subpopoulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Transpl Immunol 1996; 4: 319-323.
19. + Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
20. Talmadge JE, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
21. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413-425.
22. Atkinson K, Storb R, Prentice RL et al. Analysis of late infections in 89 long term survivors of bone marrow transplantation. Blood 1979; 53: 720-731.
23. Meyers J. Infection in bone marrow transplant recipients. Am J Med 1986; 81: 27.
24. Paulin T, Ringden O, Nilsson B et al. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987; 43: 393.
25. Wingard JR. Infections in allogeneic bone marrow transplant recipients. Semin Oncol 1993; 20: 80-87.
26. Brown RA, Adkins D, Goodnough LT et al. Factors which influence the collection and engraftment of allogeneic peripheral blood stem cells. J Clin Oncol 1997; 15: 3067-3074.
27. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-malched sibling donors. Transplantation 1974; 18: 295-304.
28. Shulman H, Sullivan K, Weiden P. Chronic graft-versus-host syndrome in man. Am J Med 1980; 69: 204-217.
29. Brown RA, Adkins D, Goodnough LT et al. Graft-vs-host disease and transplant related mortality after allogeneic peripheral blood stem cell transplantation for resistant hematologic malignancy. J Clin Oncol (in press).
30. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
31. DiPersio J, Martin B, Abboud CN et al. Increased rates of CMV viremia in recipients of peripheral blood stem cells (PBSC) allogeneic transplants: rationale for both prophylactic therapy and short course single daily dosing of gancyclovir for 21 days. Blood 1996; 88: 424a.
32. Barry TS, Jones DM, Richter CB, Haynes BF. Successful engraftment of human postnatal thymus in severe combined deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J Exp Med 1991; 173: 167.
33. Current Protocols in Immunology 1994; vol. 1, 7.11.1-7.12.6.
34. Sundaresan RS, Alevy YG, Steward N et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. J Heart Lung Transpl 1995; 14: 512-518.
35. Naziruddin B, Duffy B, Tucker J, Mohanakumar T. Evidence for cross-regulation of Fc-gamma-RIIIB (CD16) receptor-mediated signaling by Fc-gamma-RII (CD32) expressed on polymorphonuclear neutrophils. J Immunol 1992; 149: 3702-3709.
36. 2+ indicators with greatly improved fluorescein properties. J Biol Chem 1985; 260: 3440-3450.
37. Rosenfeld C, Collins R, Pineiro L et al. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol 1996; 14: 1314-1319.
38. Bacigalupo A, VanLint MT, Valbonesi M et al. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood stem cells in adults with advanced leukemia. Blood 1996; 88: 353-357.
39. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
40. Vogelsang GB, Wagner JE. Graft-versus-host disease. Hematol/Oncol Clin 1990; 4: 625-639.
41. Soiffer RJ, Bosserman L, Murray C et al. Reconstitution of T cell function after CD6-depleted allogeneic bone marrow transplantation. Blood 1990; 75: 2076-2084.
42. Ueda M, Harada M, Shiobara S et al. T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation. Transplantation 1984; 37: 552-556.
43. Witherspoon RP, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 1984; 21: 2-10.
44. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
45. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
46. Ottinger HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
47. Dokhelar MC, Wiels J, Lipinski M et al. Natural killer cell activity in human bone marrow recipients. Early reappearance of peripheral natural killer activity in graft-versus-host disease. Transplantation 1981; 31: 61-65.
48. Yamagami M, McFadden PW, Koethe SM et al. Failure of T cell receptor-anti-CD3 monoclonal antibody interaction in T cells from marrow recipients to induce increases in intracellular ionized calcium. J Clin Invest 1990; 86: 1347-1351.
49. Ino K, Singh RK, Talmadge JE. Monocytes from mobilized stem cells inhibit T cell function. J Leukocyte Biol 1997; 61: 583-591.
50. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629-1634.
51. Tanaka J, Mielcarek M. Torok-Storb B. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998; 91: 347-352.
52. Swine S, Dutton R, Schwab R, Yamamoto J. Xenogenic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses. J Exp Med 1983; 2: 720-729.
53. Heusel JW, Wesselschmidt RL, Shresta S et al. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977-987.
54. Kagi D, Ledermann B, Burki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin deficient mice. Nature 1994; 369: 31-37.
55. Arase H, Arase N, Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995; 181: 1235-1238.
56. Henkart PA. Mechanism of lymphocyte mediated cytotoxicity. Ann Rev Immunol 1988; 3: 31-58.
57. +)-independent T cell mediated cytotoxicity. J Exp Med 1993; 177: 195-200.
58. Beelen DW, Ottinger HD, Elmaagacli A et al. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with matologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 1997; 90: 4725-4735.
59. Charbonnier A, Sainty D, Faucher C et al. Immune reconstitution after blood cell transplantation. Hematol Cell Ther 1997; 39: 261-264.
60. Autran B, Malphettes M, Dhedin N et al. Studies of T cell reconstitution after hematopoietic stem cell transplant. Hematol Cell Ther 1997; 39: 252-256.
61. + cells even in the presence of exogenous IL-2. Blood 1989; 74: 2270-2277.
62. Azogui O, Gluckman E, Fradelizi D. Inhibition of IL-2 production after human allogeneic bone marrow transplantation. J Immunol 1983; 131: 1205-1208.
63. Welte K, Ciobanu M, Moore MAS et al. Defective interleukin-2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin-2. Blood 1984; 64: 380-385.
64. Kook H, Goldman F, Padley D et al. Reconstruction of the immune system after unrelated or partially matched T cell depleted bone marrow transplantation in children: immunophenotypic anlaysis and factors affecting the speed of recovery. Blood 1996; 88: 1089-1097.
65. Jin NR, Lum LG, Buren EV et al. Signal transduction by B and T cells early after bone marrow transplantation: B cell calcium flux responses are intact whereas lack of CD4 cells accounts for impaired T cell responses. Bone Marrow Transplant 1995; 16: 103-109.
66. Saxon A, McIntyre RE, Stevens RH, Gale RP. Lymphocyte dysfunction in chronic graft-versus-host disease. Blood 1981; 58: 746-751.
67. Pan L, Delmonte J, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward Type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422-4429.
68. Schneider LC, Antin JH, Weinstein H et al. Lymphokine profile in bone marrow transplant recipients. Blood 1991; 78: 3076-3080.
69. Dickinson AM, Sviland L, Hamilton PJ et al. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 65-70.
70. Rus V, Svetic A, Nguyen P et al. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J Immunol 1995; 155: 2396-2406.
71. De Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
72. Schwaighofer H, Kernan NA, O'Reilly RJ et al. Serum levels of cytokines and secondary messages after T cell depleted and non-T cell depleted bone marrow transplantation. Transplantation 1996; 62: 947-953.